Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Advanced Solid Tumor × Immune Checkpoint Inhibitors × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Pancreatic Neoplasms 2 Skin Neoplasms 1 Multiple Myeloma 1 Motor Activity 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Carcinoma, Merkel Cell 1 Advanced Solid Tumor 1

Interventions

fludarabine 1 Immune Checkpoint Inhibitors 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05916248 2025-04-01

Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors

Ruijin Hospital

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡